These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12596194)

  • 21. Epidemiology and clinical impact of glycopeptide resistance in Staphylococcus aureus.
    Ruef C
    Infection; 2004 Dec; 32(6):315-27. PubMed ID: 15597220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria.
    Mühlberg E; Umstätter F; Kleist C; Domhan C; Mier W; Uhl P
    Can J Microbiol; 2020 Jan; 66(1):11-16. PubMed ID: 31545906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The structural biology of molecular recognition by vancomycin.
    Loll PJ; Axelsen PH
    Annu Rev Biophys Biomol Struct; 2000; 29():265-89. PubMed ID: 10940250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bacteremia caused by Enterococcus gallinarum with a high level of glycopeptide resistance: 1st documented cases in Argentina].
    Togneri A; Lopardo H; Corso A
    Rev Argent Microbiol; 2003; 35(2):96-9. PubMed ID: 12920991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vancomycin resistance among strains of Enterococcus faecium].
    Sacha P; Wieczorek P; Jakoniuk P
    Przegl Lek; 2008; 65(5):229-32. PubMed ID: 18853647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. False synergy between vancomycin and beta-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods.
    Goldstein FW; Atoui R; Ben Ali A; Nguyen JC; Ly A; Kitzis MD
    Clin Microbiol Infect; 2004 Apr; 10(4):342-5. PubMed ID: 15059127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers.
    Griffin JH; Linsell MS; Nodwell MB; Chen Q; Pace JL; Quast KL; Krause KM; Farrington L; Wu TX; Higgins DL; Jenkins TE; Christensen BG; Judice JK
    J Am Chem Soc; 2003 May; 125(21):6517-31. PubMed ID: 12785792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin, teicoplanin, and ramoplanin: synthetic and mechanistic studies.
    Boger DL
    Med Res Rev; 2001 Sep; 21(5):356-81. PubMed ID: 11579438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of spontaneous resistance to glycopeptide antibiotics in staphylococcal populations.
    Biavasco F; Montanari MP; Facinelli B; Varaldo PE
    J Chemother; 1989 Jul; 1(4 Suppl):389-90. PubMed ID: 16312453
    [No Abstract]   [Full Text] [Related]  

  • 30. Formation and efficacy of vancomycin group glycopeptide antibiotic stereoisomers studied by capillary electrophoresis and bioaffinity mass spectrometry.
    Bonnici PJ; Damen M; Waterval JC; Heck AJ
    Anal Biochem; 2001 Mar; 290(2):292-301. PubMed ID: 11237332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
    Streit JM; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation and biosynthesis of carbapenem antibiotics in bacteria.
    Coulthurst SJ; Barnard AM; Salmond GP
    Nat Rev Microbiol; 2005 Apr; 3(4):295-306. PubMed ID: 15759042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzymatic synthesis of vancomycin derivatives using galactosyltransferase and sialyltransferase.
    Oh TJ; Kim DH; Kang SY; Yamaguchi T; Sohng JK
    J Antibiot (Tokyo); 2011 Jan; 64(1):103-9. PubMed ID: 21119677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogens.
    Das B; Sarkar C; Biswas R; Pandey S
    Pak J Pharm Sci; 2008 Jan; 21(1):78-87. PubMed ID: 18166524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bromobalhimycin and chlorobromobalhimycins--illuminating the potential of halogenases in glycopeptide antibiotic biosyntheses.
    Bister B; Bischoff D; Nicholson GJ; Stockert S; Wink J; Brunati C; Donadio S; Pelzer S; Wohlleben W; Süssmuth RD
    Chembiochem; 2003 Jul; 4(7):658-62. PubMed ID: 12851938
    [No Abstract]   [Full Text] [Related]  

  • 36. Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics.
    Okano A; Nakayama A; Wu K; Lindsey EA; Schammel AW; Feng Y; Collins KC; Boger DL
    J Am Chem Soc; 2015 Mar; 137(10):3693-704. PubMed ID: 25750995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Important aspects of nosocomial bacterial resistance and its management.
    Kandelaki G; Tsertsvadze T; Macharashvili N; Esugbaia M; Gogichaishvili Sh
    Georgian Med News; 2008 Dec; (165):49-54. PubMed ID: 19124917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor-bound glycosylation for various glycosyl acceptors: bidirectional solid-phase semisynthesis of vancomycin and its derivatives.
    Doi T; Kinbara A; Inoue H; Takahashi T
    Chem Asian J; 2007 Jan; 2(1):188-98. PubMed ID: 17441153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dalbavancin: a new option for the treatment of gram-positive infections.
    Lin SW; Carver PL; DePestel DD
    Ann Pharmacother; 2006 Mar; 40(3):449-60. PubMed ID: 16507624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.